Financials

  • Market Capitalization 1.75 B
  • Employee 1 600
  • Founded 1984
  • CEO James Patrick Mackin
  • Website www.artivion.com
  • Headquarter Delaware, United States
  • FIGI BBG000BMLVJ6
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
217.19
Price to sales ratio
4.87
Dividends per share
Dividend yield %

Artivion Inc

Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.

Nachrichten